Easy Access and Express Report Delivery Service
Global Radiopharmaceutical Theranostics Market Research Report 2022(Status and Outlook)
Report ID
29875
Publisher
Bosson Research
Published Date
08-Jan
Delivery Format
PDF
No of Report Page
114
Editor's Rating
-
Report Details
Report Overview Nuclear medicine therapy uses radiopharmaceuticals targeting specific tumors, such as thyroid tumors, lymphomas, or bone metastases, to deliver radiation to neoplastic lesions as part of a therapeutic strategy to cure, alleviate, or control the disease. Bosson Research’s latest report provides a deep insight into the global Radiopharmaceutical Theranostics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Radiopharmaceutical Theranostics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market. In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Radiopharmaceutical Theranostics market in any manner. Global Radiopharmaceutical Theranostics Market: Market Segmentation Analysis The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments. Key Company Nihon Medi-Physics ITM Isotopen Technologien München AG Advanced Accelerator Applications Telix Pharmaceuticals GE Healthcare Theragnostics Ltd. NuView Life Sciences Jubilant Pharma Limited Lantheus Holdings, Inc. Curium Pharma Bayer AG Clarity Pharmaceuticals Market Segmentation (by Type) Oncology Cardiology Others Market Segmentation (by Application) Hospitals Academic & Research Institutes Others Geographic Segmentation • North America (USA, Canada, Mexico) • Europe (Germany, UK, France, Russia, Italy, Rest of Europe) • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific) • South America (Brazil, Argentina, Columbia, Rest of South America) • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA) Key Benefits of This Market Research: • Industry drivers, restraints, and opportunities covered in the study • Neutral perspective on the market performance • Recent industry trends and developments • Competitive landscape & strategies of key players • Potential & niche segments and regions exhibiting promising growth covered • Historical, current, and projected market size, in terms of value • In-depth analysis of the Radiopharmaceutical Theranostics Market • Overview of the regional outlook of the Radiopharmaceutical Theranostics Market: Key Reasons to Buy this Report: • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change • This enables you to anticipate market changes to remain ahead of your competitors • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly • Provision of market value (USD Billion) data for each segment and sub-segment • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis • Provides insight into the market through Value Chain • Market dynamics scenario, along with growth opportunities of the market in the years to come • 6-month post-sales analyst support Customization of the Report In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met. Chapter Outline Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods. Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radiopharmaceutical Theranostics Market and its likely evolution in the short to mid-term, and long term. Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market. Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis. Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry. Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc. Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years. Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years. Chapter 12 is the main points and conclusions of the report.
-
Table Of Content
TABLE OF CONTENTS 1 Research Methodology and Statistical Scope 1.1 Market Definition and Statistical Scope of Radiopharmaceutical Theranostics 1.2 Key Market Segments 1.2.1 Radiopharmaceutical Theranostics Segment by Type 1.2.2 Radiopharmaceutical Theranostics Segment by Application 1.3 Methodology & Sources of Information 1.3.1 Research Methodology 1.3.2 Research Process 1.3.3 Market Breakdown and Data Triangulation 1.3.4 Base Year 1.3.5 Report Assumptions & Caveats 2 Radiopharmaceutical Theranostics Market Overview 2.1 Global Market Overview 2.1.1 Global Radiopharmaceutical Theranostics Market Size (M USD) Estimates and Forecasts (2018-2029) 2.1.2 Global Radiopharmaceutical Theranostics Sales Estimates and Forecasts (2018-2029) 2.2 Market Segment Executive Summary 2.3 Global Market Size by Region 3 Radiopharmaceutical Theranostics Market Competitive Landscape 3.1 Global Radiopharmaceutical Theranostics Sales by Manufacturers (2018-2023) 3.2 Global Radiopharmaceutical Theranostics Revenue Market Share by Manufacturers (2018-2023) 3.3 Radiopharmaceutical Theranostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4 Global Radiopharmaceutical Theranostics Average Price by Manufacturers (2018-2023) 3.5 Manufacturers Radiopharmaceutical Theranostics Sales Sites, Area Served, Product Type 3.6 Radiopharmaceutical Theranostics Market Competitive Situation and Trends 3.6.1 Radiopharmaceutical Theranostics Market Concentration Rate 3.6.2 Global 5 and 10 Largest Radiopharmaceutical Theranostics Players Market Share by Revenue 3.6.3 Mergers & Acquisitions, Expansion 4 Radiopharmaceutical Theranostics Industry Chain Analysis 4.1 Radiopharmaceutical Theranostics Industry Chain Analysis 4.2 Market Overview and Market Concentration Analysis of Key Raw Materials 4.3 Midstream Market Analysis 4.4 Downstream Customer Analysis 5 The Development and Dynamics of Radiopharmaceutical Theranostics Market 5.1 Key Development Trends 5.2 Driving Factors 5.3 Market Challenges 5.4 Market Restraints 5.5 Industry News 5.5.1 New Product Developments 5.5.2 Mergers & Acquisitions 5.5.3 Expansions 5.5.4 Collaboration/Supply Contracts 5.6 Industry Policies 6 Radiopharmaceutical Theranostics Market Segmentation by Type 6.1 Evaluation Matrix of Segment Market Development Potential (Type) 6.2 Global Radiopharmaceutical Theranostics Sales Market Share by Type (2018-2023) 6.3 Global Radiopharmaceutical Theranostics Market Size Market Share by Type (2018-2023) 6.4 Global Radiopharmaceutical Theranostics Price by Type (2018-2023) 7 Radiopharmaceutical Theranostics Market Segmentation by Application 7.1 Evaluation Matrix of Segment Market Development Potential (Application) 7.2 Global Radiopharmaceutical Theranostics Market Sales by Application (2018-2023) 7.3 Global Radiopharmaceutical Theranostics Market Size (M USD) by Application (2018-2023) 7.4 Global Radiopharmaceutical Theranostics Sales Growth Rate by Application (2018-2023) 8 Radiopharmaceutical Theranostics Market Segmentation by Region 8.1 Global Radiopharmaceutical Theranostics Sales by Region 8.1.1 Global Radiopharmaceutical Theranostics Sales by Region 8.1.2 Global Radiopharmaceutical Theranostics Sales Market Share by Region 8.2 North America 8.2.1 North America Radiopharmaceutical Theranostics Sales by Country 8.2.2 U.S. 8.2.3 Canada 8.2.4 Mexico 8.3 Europe 8.3.1 Europe Radiopharmaceutical Theranostics Sales by Country 8.3.2 Germany 8.3.3 France 8.3.4 U.K. 8.3.5 Italy 8.3.6 Russia 8.4 Asia Pacific 8.4.1 Asia Pacific Radiopharmaceutical Theranostics Sales by Region 8.4.2 China 8.4.3 Japan 8.4.4 South Korea 8.4.5 India 8.4.6 Southeast Asia 8.5 South America 8.5.1 South America Radiopharmaceutical Theranostics Sales by Country 8.5.2 Brazil 8.5.3 Argentina 8.5.4 Columbia 8.6 Middle East and Africa 8.6.1 Middle East and Africa Radiopharmaceutical Theranostics Sales by Region 8.6.2 Saudi Arabia 8.6.3 UAE 8.6.4 Egypt 8.6.5 Nigeria 8.6.6 South Africa 9 Key Companies Profile 9.1 Nihon Medi-Physics 9.1.1 Nihon Medi-Physics Radiopharmaceutical Theranostics Basic Information 9.1.2 Nihon Medi-Physics Radiopharmaceutical Theranostics Product Overview 9.1.3 Nihon Medi-Physics Radiopharmaceutical Theranostics Product Market Performance 9.1.4 Nihon Medi-Physics Business Overview 9.1.5 Nihon Medi-Physics Radiopharmaceutical Theranostics SWOT Analysis 9.1.6 Nihon Medi-Physics Recent Developments 9.2 ITM Isotopen Technologien München AG 9.2.1 ITM Isotopen Technologien München AG Radiopharmaceutical Theranostics Basic Information 9.2.2 ITM Isotopen Technologien München AG Radiopharmaceutical Theranostics Product Overview 9.2.3 ITM Isotopen Technologien München AG Radiopharmaceutical Theranostics Product Market Performance 9.2.4 ITM Isotopen Technologien München AG Business Overview 9.2.5 ITM Isotopen Technologien München AG Radiopharmaceutical Theranostics SWOT Analysis 9.2.6 ITM Isotopen Technologien München AG Recent Developments 9.3 Advanced Accelerator Applications 9.3.1 Advanced Accelerator Applications Radiopharmaceutical Theranostics Basic Information 9.3.2 Advanced Accelerator Applications Radiopharmaceutical Theranostics Product Overview 9.3.3 Advanced Accelerator Applications Radiopharmaceutical Theranostics Product Market Performance 9.3.4 Advanced Accelerator Applications Business Overview 9.3.5 Advanced Accelerator Applications Radiopharmaceutical Theranostics SWOT Analysis 9.3.6 Advanced Accelerator Applications Recent Developments 9.4 Telix Pharmaceuticals 9.4.1 Telix Pharmaceuticals Radiopharmaceutical Theranostics Basic Information 9.4.2 Telix Pharmaceuticals Radiopharmaceutical Theranostics Product Overview 9.4.3 Telix Pharmaceuticals Radiopharmaceutical Theranostics Product Market Performance 9.4.4 Telix Pharmaceuticals Business Overview 9.4.5 Telix Pharmaceuticals Radiopharmaceutical Theranostics SWOT Analysis 9.4.6 Telix Pharmaceuticals Recent Developments 9.5 GE Healthcare 9.5.1 GE Healthcare Radiopharmaceutical Theranostics Basic Information 9.5.2 GE Healthcare Radiopharmaceutical Theranostics Product Overview 9.5.3 GE Healthcare Radiopharmaceutical Theranostics Product Market Performance 9.5.4 GE Healthcare Business Overview 9.5.5 GE Healthcare Radiopharmaceutical Theranostics SWOT Analysis 9.5.6 GE Healthcare Recent Developments 9.6 Theragnostics Ltd. 9.6.1 Theragnostics Ltd. Radiopharmaceutical Theranostics Basic Information 9.6.2 Theragnostics Ltd. Radiopharmaceutical Theranostics Product Overview 9.6.3 Theragnostics Ltd. Radiopharmaceutical Theranostics Product Market Performance 9.6.4 Theragnostics Ltd. Business Overview 9.6.5 Theragnostics Ltd. Recent Developments 9.7 NuView Life Sciences 9.7.1 NuView Life Sciences Radiopharmaceutical Theranostics Basic Information 9.7.2 NuView Life Sciences Radiopharmaceutical Theranostics Product Overview 9.7.3 NuView Life Sciences Radiopharmaceutical Theranostics Product Market Performance 9.7.4 NuView Life Sciences Business Overview 9.7.5 NuView Life Sciences Recent Developments 9.8 Jubilant Pharma Limited 9.8.1 Jubilant Pharma Limited Radiopharmaceutical Theranostics Basic Information 9.8.2 Jubilant Pharma Limited Radiopharmaceutical Theranostics Product Overview 9.8.3 Jubilant Pharma Limited Radiopharmaceutical Theranostics Product Market Performance 9.8.4 Jubilant Pharma Limited Business Overview 9.8.5 Jubilant Pharma Limited Recent Developments 9.9 Lantheus Holdings, Inc. 9.9.1 Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Basic Information 9.9.2 Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Product Overview 9.9.3 Lantheus Holdings, Inc. Radiopharmaceutical Theranostics Product Market Performance 9.9.4 Lantheus Holdings, Inc. Business Overview 9.9.5 Lantheus Holdings, Inc. Recent Developments 9.10 Curium Pharma 9.10.1 Curium Pharma Radiopharmaceutical Theranostics Basic Information 9.10.2 Curium Pharma Radiopharmaceutical Theranostics Product Overview 9.10.3 Curium Pharma Radiopharmaceutical Theranostics Product Market Performance 9.10.4 Curium Pharma Business Overview 9.10.5 Curium Pharma Recent Developments 9.11 Bayer AG 9.11.1 Bayer AG Radiopharmaceutical Theranostics Basic Information 9.11.2 Bayer AG Radiopharmaceutical Theranostics Product Overview 9.11.3 Bayer AG Radiopharmaceutical Theranostics Product Market Performance 9.11.4 Bayer AG Business Overview 9.11.5 Bayer AG Recent Developments 9.12 Clarity Pharmaceuticals 9.12.1 Clarity Pharmaceuticals Radiopharmaceutical Theranostics Basic Information 9.12.2 Clarity Pharmaceuticals Radiopharmaceutical Theranostics Product Overview 9.12.3 Clarity Pharmaceuticals Radiopharmaceutical Theranostics Product Market Performance 9.12.4 Clarity Pharmaceuticals Business Overview 9.12.5 Clarity Pharmaceuticals Recent Developments 10 Radiopharmaceutical Theranostics Market Forecast by Region 10.1 Global Radiopharmaceutical Theranostics Market Size Forecast 10.2 Global Radiopharmaceutical Theranostics Market Forecast by Region 10.2.1 North America Market Size Forecast by Country 10.2.2 Europe Radiopharmaceutical Theranostics Market Size Forecast by Country 10.2.3 Asia Pacific Radiopharmaceutical Theranostics Market Size Forecast by Region 10.2.4 South America Radiopharmaceutical Theranostics Market Size Forecast by Country 10.2.5 Middle East and Africa Forecasted Consumption of Radiopharmaceutical Theranostics by Country 11 Forecast Market by Type and by Application (2023-2029) 11.1 Global Radiopharmaceutical Theranostics Market Forecast by Type (2023-2029) 11.1.1 Global Forecasted Sales of Radiopharmaceutical Theranostics by Type (2023-2029) 11.1.2 Global Radiopharmaceutical Theranostics Market Size Forecast by Type (2023-2029) 11.1.3 Global Forecasted Price of Radiopharmaceutical Theranostics by Type (2023-2029) 11.2 Global Radiopharmaceutical Theranostics Market Forecast by Application (2023-2029) 11.2.1 Global Radiopharmaceutical Theranostics Sales (K Units) Forecast by Application 11.2.2 Global Radiopharmaceutical Theranostics Market Size (M USD) Forecast by Application (2023-2029) 12 Conclusion and Key Findings
-
Inquiry Before Buying
WHY CHOOSE US
Discover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday -
Request Sample
WHY CHOOSE US
Easy Access and Express Report Delivery ServiceDiscover Business Growth OpportunitiesMore than 10 Years Experience Employee SupportIn-depth and Comprehensive Analysis100+ Client Queries Handled Everyday
